F/M Emerald Life Sciences Innovation ETF
LFSCNASDAQF/m InvestmentsEquity
As of Oct 23, 2026 close
- Assets (AUM)
- $120.65M
- Expense ratio
- 0.54%
- Dividend yield
- -
- Holdings
- 42
- 52-week range
- $30.69$48.78
- Volume (live)
- -
- Avg. volume (3M)
- 3.26K
LFSC ETF: F/M Emerald Life Sciences Innovation ETF - Price, Holdings & Analysis
F/M Emerald Life Sciences Innovation ETF Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $41.59 - $42.17 |
|---|---|
| 52-Week High | $48.78 |
| 52-Week Low | $30.69 |
| Open | $42.17 |
| Volume (last close) | 761 |
| Average Volume (3M) | 3.26K |
| 1 Day Change | −0.42% |
|---|---|
| 1 Month Change | −4.26% |
| 6 Month Change | +13.84% |
| YTD Change | +17.15% |
| 1 Year Change | +38.24% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Assets (AUM) | $120.65M |
|---|---|
| Expense Ratio | 0.54% |
| Total Holdings | 42 |
| Inception Date | Oct 30, 2024 |
| 50-Day MA | $44.97 |
|---|---|
| 200-Day MA | $40.32 |
| RSI | 46.45 |
| Stochastic %K | 60.83 |
| Stochastic %D | 27.93 |
Source: Exchange price data and fund disclosures. Data as of Oct 23, 2026. Data sources and methodology
LFSC at a Glance
F/M Emerald Life Sciences Innovation ETF (LFSC) is an equity ETF from F/m Investments, launched in October 2024. It manages $120.65M in assets and charges a 0.54% expense ratio, about $54 a year per $10,000 invested.
As of its Oct 4, 2026 holdings, it holds 42 positions. The largest are Travere Therapeutics Inc (TVTX, 7.63%), Corcept Therapeutics Incorporated (CORT, 7.13%) and LivaNova PLC (LIVN, 6.68%). The top 10 holdings make up 54.4% of the fund. By sector it leans toward Healthcare (100.0%). 94.7% of assets are in the United States.
It does not currently pay distributions. As of the Oct 23, 2026 close, the share price is up 38.2% over one year (price change, excluding distributions).
Frequently Asked Questions About F/M Emerald Life Sciences Innovation ETF
What is the current price of LFSC?
The latest LFSC price is $41.59 (Oct 23, 2026 close). The 52-week range is $30.69–$48.78. The share price is up 38.2% over the past year (price change, excluding distributions).
What is the expense ratio for LFSC?
LFSC's annual expense ratio is 0.54%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does LFSC pay dividends?
F/M Emerald Life Sciences Innovation ETF does not currently pay dividends. Check the ETF Screener for dividend-focused alternatives in the Equity category.
What are the top holdings of LFSC?
As of Oct 4, 2026, LFSC's largest holdings are Travere Therapeutics Inc (7.6%), Corcept Therapeutics Incorporated (7.1%), LivaNova PLC (6.7%) (combined weight: 21.4%). The fund holds 42 total positions. View the complete portfolio breakdown in the Holdings section.
How does LFSC compare to similar ETFs?
Compare LFSC (0.54% expense ratio, $121M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.